| Financial Year |
March 31 2023 |
| Monetary Funds |
342,081,572.40 |
| Held-for-trading Financial Assets |
75,183,901.13 |
| Notes Receivable |
6,650,000.00 |
| Accounts Receivable |
325,503,205.39 |
| Advances to Suppliers |
33,467,926.68 |
| Other Receivables |
5,050,768.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
439,272,657.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,531,558.98 |
| Total Current Assets |
1,360,911,469.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,973,401,372.15 |
| Under-construction Projects |
271,369,973.93 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
179,779,651.96 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
45,924,817.73 |
| Deferred Income Tax Assets |
60,319,083.25 |
| Other Non-Current Assets |
151,947,539.66 |
| Sub-Total of Non-Current Assets |
2,754,631,719.22 |
| Total Assets |
4,115,543,188.81 |
| Short-Term Loans |
160,006,630.18 |
| Trading Financial liabilities |
-- |
| Notes Payable |
279,940,424.83 |
| Accounts Payable |
336,223,095.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,560,423.10 |
| Taxes Payable |
30,362,938.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
37,046,771.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
37,417,313.41 |
| Other Current Liabilities |
35,001,946.72 |
| Sub-Total of Current Liabilities |
953,164,262.25 |
| Long-term Loans |
-- |
| Bonds Payable |
665,153,576.07 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,102,353.00 |
| Deferred Income Tax Liabilities |
21,870,495.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
759,742,309.57 |
| Total Liabilities |
1,712,906,571.82 |
| Paid-In Capital(Or Share Stock) |
961,953,539.00 |
| Capital Surplus |
760,014,973.65 |
| Surplus Reserve |
68,581,449.44 |
| LESS:Treasury Stock |
26,219,163.60 |
| Undistributed Profits |
540,628,075.02 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,402,636,616.99 |
| Owner's Equity（Stockholder's Equity） |
2,402,636,616.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,115,543,188.81 |
